AI制药站上风口！ETF怎么投？

新浪基金09-17

　　9月16日，AI制药领域三笔重磅合作同日落地：

　　1、字节跳动孵化的Anew Labs完成2.9亿美元首轮外部融资正式独立。

　　2、诺和诺德与Anthropic合作将Claude大模型引入新药研发核心流程。

　　3、礼来旗下TuneLab携手金斯瑞打通AI设计后的规模化湿实验验证。

　　⛓️ AI制药产业化加速，投资工具关注👇🏻

　　🧬 AI制药含量近70%

　　🏥 港股通医疗ETF华宝#159137

　　🧬 AI+CRO、AI医疗

　　🏥 医疗ETF华宝#512170

　　🧬 AI+Biotech

　　💊 港股通创新药ETF华宝#520880

　　🧬 AI+Biotech

　　💊 药ETF华宝#562050

　　🐲 投龙头 · 选华宝

　　⚠️ 市场有风险投资须谨慎！

MACD金叉信号形成，这些股涨势不错！

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2668692149?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-09-17 19:06","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2668692149","market":"sg","top_or_hot":-1,"title":"AI制药站上风口！ETF怎么投？","media":"新浪基金","content":"<html><body><div>\n<p>　　9月16日，AI制药领域三笔重磅合作同日落地：</p>\n<p>　　1、字节跳动孵化的Anew Labs完成2.9亿美元首轮外部融资正式独立。</p>\n<p>　　2、诺和诺德与Anthropic合作将Claude大模型引入新药研发核心流程。</p>\n<p>　　3、礼来旗下TuneLab携手<a href=\"https://laohu8.com/S/01548\">金斯瑞</a>打通AI设计后的规模化湿实验验证。</p>\n<p>　　⛓️ AI制药产业化加速，投资工具关注👇🏻</p>\n<p>　　🧬 AI制药含量近70%</p>\n<p>　　🏥 港股通医疗ETF<a href=\"https://laohu8.com/S/300741\">华宝</a>#159137</p>\n<p>　　🧬 AI+CRO、AI医疗</p>\n<p>　　🏥 医疗ETF华宝#512170</p>\n<p>　　🧬 AI+Biotech</p>\n<p>　　💊 <a href=\"https://laohu8.com/S/520880\">港股通创新药ETF华宝</a>#520880</p>\n<p>　　🧬 AI+Biotech</p>\n<p>　　💊 药ETF华宝#562050</p>\n<p>　　🐲 投龙头 · 选华宝</p>\n<p>　　⚠️ 市场有风险 投资须谨慎！</p>\n<div>\n<span>MACD金叉信号形成，这些股涨势不错！</span>\n</div>\n</div></body></html>","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AI制药站上风口！ETF怎么投？</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAI制药站上风口！ETF怎么投？\n</h2>\n\n<h4 class=\"meta\">\n\n</h4>\n\n</header>\n<article>\n<html><body><div>\n<p>　　9月16日，AI制药领域三笔重磅合作同日落地：</p>\n<p>　　1、字节跳动孵化的Anew Labs完成2.9亿美元首轮外部融资正式独立。</p>\n<p>　　2、诺和诺德与Anthropic合作将Claude大模型引入新药研发核心流程。</p>\n<p>　　3、礼来旗下TuneLab携手<a href=\"https://laohu8.com/S/01548\">金斯瑞</a>打通AI设计后的规模化湿实验验证。</p>\n<p>　　⛓️ AI制药产业化加速，投资工具关注👇🏻</p>\n<p>　　🧬 AI制药含量近70%</p>\n<p>　　🏥 港股通医疗ETF<a href=\"https://laohu8.com/S/300741\">华宝</a>#159137</p>\n<p>　　🧬 AI+CRO、AI医疗</p>\n<p>　　🏥 医疗ETF华宝#512170</p>\n<p>　　🧬 AI+Biotech</p>\n<p>　　💊 <a href=\"https://laohu8.com/S/520880\">港股通创新药ETF华宝</a>#520880</p>\n<p>　　🧬 AI+Biotech</p>\n<p>　　💊 药ETF华宝#562050</p>\n<p>　　🐲 投龙头 · 选华宝</p>\n<p>　　⚠️ 市场有风险 投资须谨慎！</p>\n<div>\n<span>MACD金叉信号形成，这些股涨势不错！</span>\n</div>\n</div></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.sina.com.cn/money/fund/etf/2026-09-17/doc-iniscvfx3581124.shtml\">新浪基金</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01477","symbol_name":"欧康维视生物-B","start_time":0,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-17/doc-iniscvfx3581124.shtml","article_id":"2668692149","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2668692149","pubTimestamp":1789643160,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"9月16日，AI制药领域三笔重磅合作同日落地：1、字节跳动孵化的Anew Labs完成2.9亿美元首轮外部融资正式独立。AI制药产业化加速，投资工具关注 AI制药含量近70% 港股通医疗ETF华宝#159137 AI+CRO、AI医疗 医疗ETF华宝#512170 AI+Biotech 港股通创新药ETF华宝#520880 AI+Biotech 药ETF华宝#562050 投龙头 · 选华宝 市场有风险 投资须谨慎！","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"01477":"欧康维视生物-B","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","BK1191":"制药","BK4550":"红杉资本持仓","BK4588":"碎股","QTOC":"Innovator Growth Accelerated Plus ETF - October","FDN":"First Trust Dow Jones Internet I","AGIX":"通用人工智能 ETF-AGIX","ARTY":"ISHARES FUTURE AI & TECH ETF","BK1574":"生物医药B类股","AIPO":"Defiance AI and Power Infrastructure ETF","BK4585":"ETF&股票定投概念","VTHR":"Vanguard Russell 3000 ETF"},"translate_title":"AI-powered pharmaceuticals are on the rise! How do I invest in ETFs?","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AIPO":1.5,"QTOC":1.5,"FDN":1.5,"VTHR":1.5,"CHAT":1.5,"AGIX":1.5,"ARTY":1.5,"01477":1.5},"content_text":"9月16日，AI制药领域三笔重磅合作同日落地：\n　　1、字节跳动孵化的Anew Labs完成2.9亿美元首轮外部融资正式独立。\n　　2、诺和诺德与Anthropic合作将Claude大模型引入新药研发核心流程。\n　　3、礼来旗下TuneLab携手金斯瑞打通AI设计后的规模化湿实验验证。\n　　⛓️ AI制药产业化加速，投资工具关注👇🏻\n　　🧬 AI制药含量近70%\n　　🏥 港股通医疗ETF华宝#159137\n　　🧬 AI+CRO、AI医疗\n　　🏥 医疗ETF华宝#512170\n　　🧬 AI+Biotech\n　　💊 港股通创新药ETF华宝#520880\n　　🧬 AI+Biotech\n　　💊 药ETF华宝#562050\n　　🐲 投龙头 · 选华宝\n　　⚠️ 市场有风险 投资须谨慎！\n\nMACD金叉信号形成，这些股涨势不错！","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2668692149","isCrawlerRequest":true}